DMRA Damora Therapeutics, Inc.

NASDAQ

$21.08

Damora Therapeutics, Inc. (DMRA) Earnings News

Earnings press releases, previews and reviews for Damora Therapeutics, Inc. (DMRA), newest first.

Monday August 10, 2026 4:05 PM ET

Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Tuesday May 12, 2026 4:05 PM ET

Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights